Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kishimoto

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Japanese Circulation Journal|December 1, 1984
The protection of coenzyme Q10 against experimental viral myocarditis in miceC Kishimoto, S Tamaki, A Matsumori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditisY Hiraoka, C Kishimoto, M Kurokawa, et al.
Journal of Molecular and Cellular Cardiology|December 13, 2000
Protection against murine coxsackievirus B3 myocarditis by T cell vaccinationC Kishimoto, H Takada, Y Hiraoka, et al.
Heart and Vessels|January 1, 1997
Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditisC Kishimoto, H Takada, Y Hiraoka, et al.
Journal of Virology|January 11, 2001
Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2C Kishimoto, H Kawamata, S Sakai, et al.
Journal of the American College of Cardiology|November 25, 2000
Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix changeC Kishimoto, N Takamatsu, H Kawamata, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokinesC Kishimoto, H Takada, H Kawamata, et al.
Heart and Vessels|January 1, 1997
Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in miceC Kishimoto, Y Hiraoka, H Takada, et al.
Cardiovascular Research|October 1, 1986
Animal model of silent myocarditis in athymic miceC Kishimoto, K Kuribayashi, T Masuda, et al.
Circulation|June 1, 1985
Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu miceC Kishimoto, K Kuribayashi, T Masuda, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Japanese Circulation Journal|December 1, 1984
The protection of coenzyme Q10 against experimental viral myocarditis in miceC Kishimoto, S Tamaki, A Matsumori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditisY Hiraoka, C Kishimoto, M Kurokawa, et al.
Journal of Molecular and Cellular Cardiology|December 13, 2000
Protection against murine coxsackievirus B3 myocarditis by T cell vaccinationC Kishimoto, H Takada, Y Hiraoka, et al.
Heart and Vessels|January 1, 1997
Effects of levamisole, an immunomodulator, upon murine encephalomyocarditis virus myocarditisC Kishimoto, H Takada, Y Hiraoka, et al.
Journal of Virology|January 11, 2001
Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2C Kishimoto, H Kawamata, S Sakai, et al.
Journal of the American College of Cardiology|November 25, 2000
Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix changeC Kishimoto, N Takamatsu, H Kawamata, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokinesC Kishimoto, H Takada, H Kawamata, et al.
Heart and Vessels|January 1, 1997
Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in miceC Kishimoto, Y Hiraoka, H Takada, et al.
Cardiovascular Research|October 1, 1986
Animal model of silent myocarditis in athymic miceC Kishimoto, K Kuribayashi, T Masuda, et al.
Circulation|June 1, 1985
Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu miceC Kishimoto, K Kuribayashi, T Masuda, et al.
Pageof 8